350 related articles for article (PubMed ID: 8825713)
1. Follow-up study of clinical and immunological findings in patients presenting with acute parvovirus B19 infection.
Kerr JR; Coyle PV; DeLeys RJ; Patterson CC
J Med Virol; 1996 Jan; 48(1):68-75. PubMed ID: 8825713
[TBL] [Abstract][Full Text] [Related]
2. Chronic fatigue syndrome and arthralgia following parvovirus B19 infection.
Kerr JR; Bracewell J; Laing I; Mattey DL; Bernstein RM; Bruce IN; Tyrrell DA
J Rheumatol; 2002 Mar; 29(3):595-602. PubMed ID: 11911112
[TBL] [Abstract][Full Text] [Related]
3. Antibody-mediated opsonization of red blood cells in parvovirus B19 infection.
Chehadeh W; Halim MA; Al-Nakib W
Virology; 2009 Jul; 390(1):56-63. PubMed ID: 19450862
[TBL] [Abstract][Full Text] [Related]
4. Human parvovirus B19 infection during pregnancy--value of modern molecular and serological diagnostics.
Enders M; Schalasta G; Baisch C; Weidner A; Pukkila L; Kaikkonen L; Lankinen H; Hedman L; Söderlund-Venermo M; Hedman K
J Clin Virol; 2006 Apr; 35(4):400-6. PubMed ID: 16332455
[TBL] [Abstract][Full Text] [Related]
5. Serological and virological markers of human parvovirus B19 infection in sera of hemophiliacs.
Grosse-Bley A; Eis-Hübinger AM; Kaiser R; Oldenburg J; Brackmann HH; Schwarz TF; Schneweis KE
Thromb Haemost; 1994 Oct; 72(4):503-7. PubMed ID: 7878623
[TBL] [Abstract][Full Text] [Related]
6. Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection.
Von Landenberg P; Lehmann HW; Knöll A; Dorsch S; Modrow S
Arthritis Rheum; 2003 Jul; 48(7):1939-47. PubMed ID: 12847688
[TBL] [Abstract][Full Text] [Related]
7. [Parvovirus B19 infection: the general aspects and gestational problems].
Di Stefano L; Carta G; Barnabei R; Tomei E; Toro G; Moscarini M
Minerva Ginecol; 1995 Apr; 47(4):121-5. PubMed ID: 7644092
[TBL] [Abstract][Full Text] [Related]
8. Antibody response to B19 parvovirus VP1 and VP2 linear epitopes in patients with haemophilic arthritis.
Azzi A; Manaresi E; Zakrzewska K; DeSantis R; Musiani M; Zerbini M
J Med Virol; 2004 Apr; 72(4):679-82. PubMed ID: 14981773
[TBL] [Abstract][Full Text] [Related]
9. The association of VP1 unique region protein in acute parvovirus B19 infection and anti-phospholipid antibody production.
Tzang BS; Tsay GJ; Lee YJ; Li C; Sun YS; Hsu TC
Clin Chim Acta; 2007 Mar; 378(1-2):59-65. PubMed ID: 17169353
[TBL] [Abstract][Full Text] [Related]
10. [The use of real-time polymerase chain reaction and enzyme immunoassay for the diagnosis of acute parvovirus B19 infections in immunosuppressed patients].
Işik N; Ağaçfidan A; Ağirbaşli H; Işik DM; Bozkaya E; Gedikoğlu G; Badur S
Mikrobiyol Bul; 2003 Oct; 37(4):277-83. PubMed ID: 14748265
[TBL] [Abstract][Full Text] [Related]
11. Antibody to parvovirus B19 nonstructural protein is associated with chronic arthralgia in patients with chronic fatigue syndrome/myalgic encephalomyelitis.
Kerr JR; Gough J; Richards SC; Main J; Enlander D; McCreary M; Komaroff AL; Chia JK
J Gen Virol; 2010 Apr; 91(Pt 4):893-7. PubMed ID: 20007355
[TBL] [Abstract][Full Text] [Related]
12. Clinical and epidemiological aspects of human parvovirus B19 infection in an urban area in Brazil (Niterói city area, State of Rio de Janeiro, Brazil).
Oliveira SA; Camacho LA; Pereira AC; Faillace TF; Setubal S; Nascimento JP
Mem Inst Oswaldo Cruz; 2002 Oct; 97(7):965-70. PubMed ID: 12471422
[TBL] [Abstract][Full Text] [Related]
13. CD4(+) T-cell responses against the VP1-unique region in individuals with recent and persistent parvovirus B19 infection.
Lindner J; Barabas S; Saar K; Altmann D; Pfister A; Fleck M; Deml L; Modrow S
J Vet Med B Infect Dis Vet Public Health; 2005; 52(7-8):356-61. PubMed ID: 16316401
[TBL] [Abstract][Full Text] [Related]
14. Parvovirus B19 viral loads in relation to VP1 and VP2 antibody responses in diagnostic blood samples.
Beersma MF; Claas EC; Sopaheluakan T; Kroes AC
J Clin Virol; 2005 Sep; 34(1):71-5. PubMed ID: 15985386
[TBL] [Abstract][Full Text] [Related]
15. Parvovirus infection in children with AIDS: high prevalence of B19-specific immunoglobulin M and G antibodies.
Nigro G; Luzi G; Fridell E; Ferrara M; Pisano P; Gattinara GC; Mezzaroma I; Söderlund M; Rasnoveanu D; Aiuti F
AIDS; 1992 Jul; 6(7):679-84. PubMed ID: 1503687
[TBL] [Abstract][Full Text] [Related]
16. Quantitative analysis of neutralizing immune responses to human parvovirus B19 using a novel reverse transcriptase-polymerase chain reaction-based assay.
Bostic JR; Brown KE; Young NS; Koenig S
J Infect Dis; 1999 Mar; 179(3):619-26. PubMed ID: 9952368
[TBL] [Abstract][Full Text] [Related]
17. [Seroprevalence of B19 parvovirus infection in patients with acute polyarthritis].
Campoy Reolid E; Casanova Rituerto A; Rodríguez Moreno J; Gómez Vaquero C; Ros Expósito S; Roig Escofet D
Rev Clin Esp; 1996 Dec; 196(12):828-30. PubMed ID: 9132859
[TBL] [Abstract][Full Text] [Related]
18. Prolonged parvovirus b19 viremia in spite of neutralizing antibodies after erythema infectiosum in pregnancy.
Dobec M; Juchler A; Flaviano A; Kaeppeli F
Gynecol Obstet Invest; 2007; 63(1):53-4. PubMed ID: 16940737
[TBL] [Abstract][Full Text] [Related]
19. Circulating cytokines and chemokines in acute symptomatic parvovirus B19 infection: negative association between levels of pro-inflammatory cytokines and development of B19-associated arthritis.
Kerr JR; Cunniffe VS; Kelleher P; Coats AJ; Mattey DL
J Med Virol; 2004 Sep; 74(1):147-55. PubMed ID: 15258981
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies following parvovirus B19 infection.
Kerr JR; Boyd N
J Infect; 1996 Jan; 32(1):41-7. PubMed ID: 8852550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
